Healthcare - Biotechnology - NASDAQ - US
$ 1.21
-3.97 %
$ 20.4 M
Market Cap
-0.95
P/E
INCOME STATEMENT
0
REVENUE
-44.7 M
OPERATING INCOME
-39.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Unity Biotechnology, Inc.
| Revenue | 0 |
| Cost Of Revenue | 19.7 M |
| Gross Profit | -19.7 M |
| Operating Expenses | 44.7 M |
| Operating Income | -44.7 M |
| Other Expenses | -4.81 M |
| Net Income | -39.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0.2 | 4.8 | 0 | 0 | 0 | 1.4 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 19.7 | 2.2 | 2.9 | 3.4 | 2.7 | 2.2 | 37.4 | 0.2 |
| Gross Profit | (19.7) | (1.9) | 1.9 | (3.4) | (2.7) | (2.2) | (36.0) | (0.2) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 44.7 | 57.8 | 61.4 | 91.3 | 91.0 | 74.9 | 47.0 | 18.8 |
| Selling, General and Administrative Expenses | 18.8 | 20.9 | 23.1 | 24.0 | 20.0 | 16.0 | 9.6 | 5.1 |
| Research and Development Expenses | 20.1 | 36.9 | 38.4 | 67.3 | 71.0 | 58.9 | 37.4 | 13.7 |
| Operating Income | (44.7) | (57.6) | (56.7) | (93.9) | (89.7) | (79.5) | (45.6) | (18.8) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | (2.5) | 3.6 | 3.2 | 1.3 | 0 | 3.3 | 0 | 0 |
| Total Other Income | 4.8 | 13.1 | (4.1) | 86 K | 7.5 | 3.1 | 1.0 | (11.6) |
| Pre-Tax Income | (39.9) | (59.9) | (60.7) | (93.8) | (82.2) | (76.4) | (44.7) | (30.4) |
| NET INCOME | ||||||||
| Tax Provision | 0 | (2.2) | (0.7) | (2.0) | (7.3) | 3.1 | (1.1) | 11.6 |
| Net Income | (39.9) | (57.7) | (60.0) | (91.9) | (74.9) | (76.4) | (44.7) | (30.4) |
| EPS | 2.7 | 6.08 | 10.8 | 18.1 | 17.2 | 27 | 130 | 88.5 |